2-氟-5-甲氧基苯胺 | 62257-15-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 中文名称: 2-氟-5-甲氧基苯胺
• 中文别名: 3-氨基-4-氟苯甲醚
• 英文名称: 2-fluoro-5-methoxyaniline
• CAS: 62257-15-2
• 化学式: C₇H₈FNO
• mdl: MFCD11226283
• 分子量: 141.145
• InChiKey: RUTKJXMYXZFXPQ-UHFFFAOYSA-N

物化性质

• 沸点：
  237.6±20.0 °C(Predicted)
• 密度：
  1.176

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.142
• 拓扑面积：
  35.2
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 海关编码：
  2922299090
• 危险性防范说明：
  P280,P305+P351+P338,P310
• 危险性描述：
  H302,H315,H319,H332,H335
• 储存条件：
  2-8°C

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 2-fluoro-5-methoxyaniline
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 2-fluoro-5-methoxyaniline
CAS number: 62257-15-2

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels, refrigerated.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C7H8FNO
Molecular weight: 141.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen fluoride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-氟-5-甲氧基苯胺 在 苯甲酰基异硫氰酸酯 、 sodium hydroxide 、 盐酸 作用下， 以 丙酮 、 水 为溶剂， 反应 2.0h， 以77%的产率得到1-(2-氟-5-甲氧基苯基)硫脲
  参考文献：
  名称：

  Novel Bicyclic Pyridinones

  摘要：

  所述化合物及其药用可接受的盐被披露，其中所述化合物具有如本文所定义的Formula I的结构。相应的药物组合物、治疗方法、合成方法和中间体也被披露。

  公开号：

  US20120252758A1
• 作为产物：
  描述：

  1-甲氧基-3-亚硝基苯 在 sodium tetrahydroborate 、 溶剂黄146 、 N-氟代双苯磺酰胺 、 potassium nitrate 、 copper(l) chloride 、 bis(dibenzylideneacetone)-palladium⁽⁰⁾ 作用下， 以 乙醇 、 乙酸乙酯 为溶剂， 反应 24.0h， 生成 2-氟-5-甲氧基苯胺
  参考文献：
  名称：

  阴离子配体促进选择性的C–F键还原消除，使C（sp 2）–H氟化†

  摘要：

  报道了有关阴离子配体促进选择性C–H键氟化的详细机理研究。阴离子配体的作用已通过实验证据和DFT计算得以阐明。此外，硝酸盐促进了C–F键的还原性消除，使得各种对称和不对称的偶氮苯能够选择性地进行C–H键氟化，从而获得各种邻氟苯胺。

  DOI：

  10.1039/c9cc07726j
• 作为试剂：
  描述：

  4-羟基-2-(甲基磺酰基)嘧啶-5-羧酸乙酯 、 2-氟-5-甲氧基苯胺 在 2-氟-5-甲氧基苯胺 、 2-(2-fluoro-5-methoxy-phenylamino)-6-oxo-1,6-dihydro-pyrimidine-5-carboxylic acid ethyl ester 作用下， 反应 2.03h， 生成 2-(2-fluoro-5-methoxy-phenylamino)-6-oxo-1,6-dihydro-pyrimidine-5-carboxylic acid ethyl ester
  参考文献：
  名称：

  Pyrimidine Derivatives

  摘要：

  本发明涉及一种具有有趣药理学特性的嘧啶衍生物。

  公开号：

  US20100010025A1

文献信息

• [EN] IMIDAZOLYL-IMIDAZOLES AS KINASE INHIBITORS<br/>[FR] IMIDAZOLYL-IMIDAZOLES EN TANT QU'INHIBITEURS DE KINASE
  申请人：GLAXO GROUP LTD

  公开号：WO2011123609A1

  公开（公告）日：2011-10-06

  Disclosed are compounds having the formula: wherein R1A, R1B, R2 and R3 are as defined herein, and methods of making and using the same.

  揭示了具有以下公式的化合物：其中R1A、R1B、R2和R3如本文所定义，并且制备和使用这些化合物的方法。
• [EN] INDAZOLE- AND PYRROLOPYRIDINE-DERIVATIVE AND PHARMACEUTICAL USE THEREOF<br/>[FR] DÉRIVÉ D'INDAZOLE ET PYRROLOPYRIDINE ET UTILISATION PHARMACEUTIQUE DE CELUI-CI
  申请人：DAINIPPON SUMITOMO PHARMA CO

  公开号：WO2012169649A1

  公开（公告）日：2012-12-13

  The present invention relates to a novel indazole- or pyrrolopyridine-derivative, represented by the formula (1) below, that has an agonistic action or a partial agonistic action against serotonin-4 receptor, and a pharmaceutical composition comprising the same. Formula (1) [wherein each substituent is as defined in claim 1]

  本发明涉及一种新型吲唑基或吡咯吡啶基衍生物，由下面的式（1）表示，该衍生物对5-羟色胺-4受体具有激动作用或部分激动作用，并且包括含有该衍生物的药物组合物。式（1）[其中每个取代基如权利要求1所定义]
• 一种合成2-氟苯胺化合物的方法
  申请人：浙江工业大学

  公开号：CN109704987B

  公开（公告）日：2021-10-15

  本发明公开了一种合成2‑氟苯胺化合物的方法，所述方法为：以式Ia所示苯胺化合物α与式Ib所示苯胺化合物β为原料，经过偶联反应制得式II所示偶氮苯化合物，再将式II所示偶氮苯化合物与钯催化剂、氟化试剂、添加剂、有机溶剂混合，在30～150℃温度下密闭搅拌进行氟化反应，制得式III所示的化合物，式III所示的化合物在还原剂的作用下反应制得式IV所示的2‑氟苯胺化合物；本发明合成的2‑氟苯胺化合物底物适应性广，反应条件温和，操作简单，氟化选择性好等优点，制得的邻氟苯胺化合物是许多药物分子的重要中间体和起始原料，应用前景广泛。
• Substituted tricyclics
  申请人：Eli Lilly and Company

  公开号：US06177440B1

  公开（公告）日：2001-01-23

  A class of novel tricyclics is disclosed together with the use of such compounds for inhibiting sPLA2 mediated release of fatty acids for treatment of conditions such as septic shock.

  一类新型三环化合物被披露，以及利用这类化合物抑制sPLA2介导的脂肪酸释放，用于治疗诸如感染性休克等疾病。
• FUSED HETEROCYCLIC COMPOUND
  申请人：Takeda Pharmaceutical Company Limited

  公开号：EP2103620A1

  公开（公告）日：2009-09-23

  The present invention provides a fused heterocyclic compound having a tyrosine kinase inhibitory action, which is represented by the formula: wherein R1 is a hydrogen atom, a halogen atom, or an optionally substituted group bonded via a carbon atom, a nitrogen atom or an oxygen atom; R2 is a hydrogen atom, or an optionally substituted group bonded via a carbon atom or a sulfur atom, or R1 and R2, or R2 and R3 are optionally bonded to each other to form an optionally substituted ring structure; R3 is a hydrogen atom or an optionally substituted aliphatic hydrocarbon group, or R3 is optionally bonded to the carbon atom on ring A to form an optionally substituted ring structure; ring A is an optionally substituted benzene ring; and ring B is (i) an optionally substituted fused ring, or (ii) a pyridine ring having optionally substituted carbamoyl (the pyridine ring is optionally further substituted).

  本发明提供了一种具有酪氨酸激酶抑制作用的融合杂环化合物，其化学式如下： 其中 R1是氢原子、卤素原子或通过碳原子、氮原子或氧原子键合的可选择取代基； R2是氢原子，或通过碳原子或硫原子键合的可选择取代基，或 R1和R2，或R2和R3可选择键合在一起形成可选择取代的环结构； R3是氢原子或可选择取代的脂肪烃基，或 R3可选择键合到环A上的碳原子上形成可选择取代的环结构； 环A是可选择取代的苯环；环B是 (i) 可选择取代的融合环，或 (ii) 具有可选择取代的氨基甲酰基的吡啶环（吡啶环可进一步取代）。